Legislation to beef up U.S. Customs and Border Protection’s ability to detect attempts to smuggle opioids into the country passed in the House on Tuesday.
The House voted 412-3 to approve the bill, which would authorize $9 million to ensure the CBP has chemical screening devices, scientists and other personnel available to detect the illegal importation of fentanyl and other synthetic opioids.
“The federal government must do its part to ensure our first responders have the tools they need in this greatest of public health fights,” said Rep. Niki Tsongas (D-Mass.), who authored the legislation with Rep. Brian Fitzpatrick (R-Pa.).
Fentanyl is estimated to be up to 50 times stronger than heroin and is mostly imported into the U.S. from Mexico or China. It’s typically smuggled across the U.S. border or delivered via mail, as it can be ordered online.
Generally, fentanyl is distributed in small amounts due to its potency, which makes it harder for law enforcement to detect it at checkpoints.
Sen. Edward MarkeyEdward (Ed) John MarkeyDems lambaste Trump’s ‘outrageous’ EPA chemical safety pick Dems plan to make gun control an issue in Nevada Dem senator pitches ideas for gun control after shooting MORE (D-Mass.), Sherrod BrownSherrod Campbell BrownDems plan to make gun control an issue in Nevada Mandel leads GOP primary for Ohio Senate seat: internal poll Red-state Dems need more from Trump before tax embrace MORE (D-Ohio), Marco RubioMarco Antonio RubioOvernight Defense: Tillerson, Trump deny report of rift | Tillerson says he never considered resigning | Trump expresses ‘total confidence’ in secretary | Rubio asks Army to kick out West Point grad Rubio asks Army to kick out West Point grad with pro-communist posts GOP establishment doubts Bannon’s primary powers MORE (R-Fla.) and Shelley Moore CapitoShelley Moore CapitoLawmakers try again on miners’ pension bill How the effort to replace ObamaCare failed It’s time to eliminate the secretive Pharmacy Benefit Manager pricing practices MORE (R-W.Va.) have introduced bipartisan companion legislation in the Senate.
Passage of the bill came a week after a Washington Post and “60 Minutes” joint investigation found that Congress had passed a bill in 2016 that hindered the Drug Enforcement Administration’s (DEA) efforts to combat the opioid crisis.
Rep. Tom Marino (R-Pa.) withdrew his name for consideration as President Trump’s drug czar after the investigation revealed his role in pushing the bill, which made it harder for the DEA to stop prescription opioids from being supplied to doctors and pharmacists suspected of selling narcotics on the black market.